Accelerate Diagnostics
AXDX
#10564
Rank
S$1.11 M
Marketcap
S$0.04405
Share price
0.00%
Change (1 day)
-98.07%
Change (1 year)

Accelerate Diagnostics (AXDX) - P/B ratio

P/B ratio as of December 2025 : -0.0153

According to Accelerate Diagnostics's latest financial reports the company has a price-to-book ratio of 0.0735097.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Accelerate Diagnostics - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-0.4916-82.86%
2023-12-31-2.87-8.74%
2022-12-31-3.14-69.69%
2021-12-31-10.449.15%
2020-12-31-6.95-94.45%
2019-12-31-125-1252.7%
2018-12-3110.9-11.1%
2017-12-3112.2-10.85%
2016-12-3113.765.85%
2015-12-318.27-36.29%
2014-12-3113.06.06%
2013-12-3112.261.12%
2012-12-317.60163.35%
2011-12-312.8835.04%
2010-12-312.14-13.17%
2009-12-312.46-55.19%
2008-12-315.49-47.54%
2007-12-3110.5225.76%
2006-12-313.21-5.53%
2005-12-313.4082.51%
2004-12-311.867.67%
2003-12-311.7371.5%
2002-12-311.01

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Thermo Fisher Scientific
TMO
4.21-27,531.62%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
1.80-11,826.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.19-14,393.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
1.28-8,450.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-0.1002 553.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
2.91-19,090.07%๐Ÿ‡บ๐Ÿ‡ธ USA